Clinical trial
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
NCT00051909 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00051909 |
|---|---|
| Title | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease |
| Official title | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | LY451395 |
| Enrollment | 200 |
| Start date | Nov 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Jan 20, 2003 |
| Last update posted | Jul 19, 2006 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: